Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)

The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U. S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions

credit:


using adult stem cells.

This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act.

Applications submitted in response to this bi-phasic, milestone-driven cooperative agreement FOA are expected to propose highly innovative projects with a focus on solutions to widely-recognized issues in the development of safe and effective RM therapies.

Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials.

This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan.

Trials must be relevant to the research mission of one or more participating NIH Institutes and Centers and meet the NIH definition of a clinical trial (see NOT-OD-15-015).

Applications are expected to include plans for project management, participant recruitment and retention, performance milestones, conduct of the trial, and dissemination of results.

Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans.

Successful applicants proposing the use of adult stem cells as a clinical intervention will be asked to make available representative samples of the source stem cell and clinical-grade stem cell-derived product for in-depth and independ
Related Programs

Oral Diseases and Disorders Research

Department of Health and Human Services


Research Related to Deafness and Communication Disorders

Department of Health and Human Services


National Center on Sleep Disorders Research

Department of Health and Human Services


Mental Health Research Grants

Department of Health and Human Services


National Center for Advancing Translational Sciences

Department of Health and Human Services


Cardiovascular Diseases Research

Department of Health and Human Services


Lung Diseases Research

Department of Health and Human Services


Blood Diseases and Resources Research

Department of Health and Human Services


Arthritis, Musculoskeletal and Skin Diseases Research

Department of Health and Human Services


Diabetes, Digestive, and Kidney Diseases Extramural Research

Department of Health and Human Services


Extramural Research Programs in the Neurosciences and Neurological Disorders

Department of Health and Human Services


Allergy, Immunology and Transplantation Research

Department of Health and Human Services


Microbiology and Infectious Diseases Research

Department of Health and Human Services


Aging Research

Department of Health and Human Services


Vision Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: $3,118,000


Who's Eligible





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-030.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-030.html

Contact:


Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:


Date Posted:
2019-08-14

Application Due Date:


Archive Date:
2019-11-23


Here are the star companies that have succeeded in their corporate social responsibility (CSR) programs. The companies were gathered by Civic 50, a national initiative to survey and rank S&P 500 corporations on how they engage with the communities they serve and utilize best practices in their corporate cultures.




Nonprofit Jobs in South Carolina

  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs
  Executive Director Jobs
  Substance Abuse Jobs





More Federal Domestic Assistance Programs


Recovery Act Funds - Habitat Enhancement, Restoration and Improvement. | Payments for Small Community Air Service Development | Agricultural Market and Economic Research | Reimbursement for Firefighting on Federal Property | Citizen Corps |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders